The association of p16INK4A and fragile histidine triad gene expression and cervical lesions

dc.contributor.authorLongatto Filho, Adhemar
dc.contributor.authorEtlinger, Daniela
dc.contributor.authorPereira, Sónia Maria Miranda
dc.contributor.authorKanamura, Cristina Takami
dc.contributor.authorLoreto, Celso di
dc.contributor.authorSantos, Gilda da Cunha
dc.contributor.authorMakabe, Sérgio
dc.contributor.authorMarques, José A.
dc.contributor.authorSantoro, Carmen L. F.
dc.contributor.authorDôres, Gerson B. das
dc.contributor.authorCastelo, A.
dc.date.accessioned2007-01-08T16:16:56Z
dc.date.available2007-01-08T16:16:56Z
dc.date.issued2007
dc.description.abstractObjective. This cross-sectional study was intended to assess the association between immunohistochemical analysis of p16INK4A and fragile histidine triad (FHIT) and the presence of precancerous cervical lesions. Materials and Methods. Women seen at Pe´ rola Byington Hospital, São Paulo, Brazil, with histologically confirmed cervicitis (n = 31), cervical intraepithelial neoplasia (CIN) 1 (n = 30), CIN 2,3 (n = 30), and cervical cancer (n = 7) had also cervical material collected for liquid-based cytology, human papillomavirus Hybrid Capture 2 (HC2) test, and p16 and FHIT immunohistochemical reactions. Results. p16 and FHIT reactions were scored as the following: G1%, 1% to 5%, 95% to 25%, and 925%. Receiver operating curve analysis was used to select p16 and FHIT score cutoffs for further categorical analyses. All but one of the 37 CIN 2,3/cancer cases had a p16 score of greater than 1% to 5%. Among the 61 cervicitis/CIN 1 cases, 46 (75%) had a p16 score lower than 1% to 5%. In contrast, no association of FHIT expression and severity of cervical lesions could be demonstrated in this data set. Receiver operating curve analyses suggested the score of 1% to 5% for p16 as the cutoff that best discriminates CIN 2,3/cancer from cervicitis/CIN 1. No cutoff for FHIT scores could be suggested with data set. Conclusions. p16, but not FHIT expression, has the potential to be used as complementary diagnostic tool to investigate human papillomavirusYinduced cervical lesions, if these results are confirmed in larger studies.eng
dc.description.sponsorship(undefined)por
dc.distributioninternationalpor
dc.identifier.citation"Journal of lower genital tract disease". ISSN 1089-2591. (2007) 1-7.eng
dc.identifier.doi10.1097/LGT.0b013e31802efb9epor
dc.identifier.issn1089-2591por
dc.identifier.pmid17596760por
dc.identifier.urihttps://hdl.handle.net/1822/5969
dc.language.isoengeng
dc.peerreviewedyespor
dc.publisherAmerican Society for Colposcopy and Cervical Pathology (ASCCP)eng
dc.rightsopenAccesseng
dc.subjectP16eng
dc.subjectCervical cancereng
dc.subjectFHITeng
dc.subjectHPVeng
dc.subjectLíquid-based cytologyeng
dc.titleThe association of p16INK4A and fragile histidine triad gene expression and cervical lesionseng
dc.typearticlepor
dspace.entity.typePublicationen
oaire.citationEndPage157por
oaire.citationIssue3por
oaire.citationStartPage151por
oaire.citationVolume11por
sdum.journalJournal of lower genital tract diseasepor
sdum.publicationstatuspublishedeng

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
p16 and SIL LGTD.pdf
Tamanho:
653.31 KB
Formato:
Adobe Portable Document Format